Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Pharmaceutics|September 28, 2023
Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer CandidatesElena Marchesi, Daniela Perrone, Maria Luisa Navacchia
Molecules (Basel, Switzerland)|December 30, 2020
Bile Acid Conjugates with Anticancer Activity: Most Recent ResearchMaria Luisa Navacchia, Elena Marchesi, Daniela Perrone
Molecules (Basel, Switzerland)|June 2, 2021
Modified Nucleosides, Nucleotides and Nucleic Acids via Click Azide-Alkyne Cycloaddition for Pharmacological ApplicationsDaniela Perrone, Elena Marchesi, Lorenzo Preti, et al.
Molecules (Basel, Switzerland)|November 27, 2024
Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 TreatmentMaria Luisa Navacchia, Caterina Cinti, Elena Marchesi, et al.
Bioconjugate Chemistry|July 26, 2013
Labeling deoxyadenosine for the preparation of functional conjugated oligonucleotidesMassimo L Capobianco, Elena Marchesi, Daniela Perrone, et al.
Molecules (Basel, Switzerland)|October 13, 2017
Rational Design of Nucleoside-Bile Acid Conjugates Incorporating a Triazole Moiety for Anticancer Evaluation and SAR ExplorationMaria Luisa Navacchia, Elena Marchesi, Lara Mari, et al.
Biomolecules|January 28, 2026
Biological Evaluation and SAR Exploration of Bile Acid-Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal CancerDaniela Perrone, Elisabetta Melloni, Lorenzo Gnudi, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Synthesis and Biological Investigation of Bile Acid-Paclitaxel HybridsElisabetta Melloni, Elena Marchesi, Lorenzo Preti, et al.
Molecules (Basel, Switzerland)|July 27, 2024
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor HybridsElena Marchesi, Elisabetta Melloni, Fabio Casciano, et al.
ACS Omega|December 4, 2023
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2Elena Marchesi, Valentina Gentili, Daria Bortolotti, et al.
Pageof 8